Merck, SurModics to develop eye-disease drugs

By IBTimes Staff Reporter | June 27 2007 7:56 AM

Merck & Co. and SurModics Inc. said on Wednesday they would seek to jointly develop drugs for eye diseases, a collaboration that could yield SurModics at least $300 million.

Sponsorship Link

SurModics will receive a licensing fee of $20 million and could receive an additional $288 million associated with the successful product development and attainment of various U.S. and European regulatory approvals.

More in Companies

United Colors of Benetton Launches 'Unhate' Campaign, Less Edgy Than Previous Ads

United Colors of Benetton Launches 'Unhate' Campaign, Less Edgy Than Previous Ads

The Korean Men Makeup Fad: South Korea Is Largest Market For Men?s Skincare In The World

The Korean Men Makeup Fad: South Korea Is Largest Market For Men?s Skincare In The World

The Top Post-Market Nasdaq Movers (Brightcove, Body Central, Renewable Energy, 3SBio, AngioDynamics, Kraft Foods, Idenix, TriQuint, Take-Two Interactive, Tree.com)

The Top Post-Market Nasdaq Movers (Brightcove, Body Central, Renewable Energy, 3SBio, AngioDynamics, Kraft Foods, Idenix, TriQuint, Take-Two Interactive, Tree.com)

Apple Tops $700 Mark, Year After Hitting $400

Apple Tops $700 Mark, Year After Hitting $400

IBTimes Magazine

Warped Magazine Editing Fee: Pay-To-Play ‘Scam’ Targeting Unwitting Punk Bands, According To Facebook And Reddit Users

Punk Bands: Would You Pay $45 To Be In A Mag You’ve Never Heard Of?

Journeys In Jaffna, Sri Lanka, 4 Years After The Civil War’s Bloody Conclusion

Inside Northern Sri Lanka 4 Years After Civil War

Drones: Which Countries Have Them For Surveillance And Military Operations? (MAP)

Where In The World Are The Military Drones? [MAP]

Borrowing To Buy: How Much Do Americans Owe?

Borrowing To Buy: How Much Do Americans Owe?

web counter